Professor of Allergy and Immunology, University Wisc
Allergy & Immunology
Dr. William W. Busse, MD
|
|
Give Review
William W. Busse, MD is an expert in the field of Allergy & Immunology. He graduated from University Hospital - University of Cincinnati College of Medicine. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAAAI)". William Busse is a published physician. He published 98 publications, including: 'Reducing Exacerbations in the Inner City: Lessons from the Inner-City Asthma Consortium (ICAC).'
Publications
- Reducing Exacerbations in the Inner City: Lessons from the Inner-City Asthma Consortium (ICAC).
- Roflumilast for Asthma: Efficacy findings in placebo-controlled studies.
- Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall Asthma exacerbations.
- Airway factor XIII associates with type 2 inflammation and airway obstruction in Asthmatic patients.
- IgE-mediated Asthma: New revelations and future insights.
- DNA methylation and childhood Asthma in the inner city.
- Seasonal risk factors for Asthma exacerbations among inner-city children.
- Phenotype of Asthmatics with increased airway S-nitrosoglutathione reductase activity.
- Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic Asthma: a phase 2b randomised dose-ranging study.
- Gene Expression in Relation to Exhaled NO Identifies Novel Asthma Phenotypes with Unique Biomolecular Pathways.
- Longitudinal changes in airway remodeling and air trapping in severe Asthma.
- Once-daily fluticasone furoate 50mcg in mild to moderate Asthma: a 24-week placebo-controlled randomized trial.
- Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children.
- Executive Summary: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.
- Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic Asthma population: a geneti...
- Development of cockroach immunotherapy by the Inner-City Asthma Consortium.
- An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe Asthma.
- Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data.
- Designing clinical trials to address the needs of childhood and adult Asthma: The National Heart, Lung, and Blood Institute's AsthmaNet.
- Authors' reply to 'Safety and tolerability of fluticasone furoate/vilanterol'.
- Glucocorticoid-induced osteoporosis: An update on Effects and management.
- Randomized, Double-blind, Placebo-controlled Study of Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma.
- Effects of benralizumab on airway eosinophils in Asthmatic patients with sputum eosinophilia.
- Characteristics of perimenstrual Asthma and its relation to Asthma severity and control: data from the severe Asthma research program.
- High eosinophil count: AÂ potential biomarker for assessing successful omalizumab treatment Effects.
- Exploring the effects of omalizumab in Allergic asthma.
- Severe Asthma: an expanding and mounting clinical challenge.
- Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents.
- Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the ?2 agonist vilanterol administered once daily for 52 weeks in p...
- An Association between L-Arginine/Asymmetric Dimethyl Arginine Balance, Obesity, and the Age of Asthma Onset Phenotype.
- Safety and efficacy of the prostaglandin D(2) receptor antagonist AMG 853 in Asthmatic patients.
- Future of Allergy/Immunology Task Force Report.
- Are There Neurophenotypes for Asthma? Functional Brain Imaging of the Interaction between Emotion and Inflammation in Asthma.
- The brain and Asthma: what are the linkages?.
- Omalizumab and the risk of malignancy: Results from a pooled analysis.
- Development and validation of the Composite Asthma Severity Index-an outcome measure for use in children and adolescents.
- Platelet Activation, P-selectin, and Eosinophil ?1-integrin Activation in Asthma.
- What is the best Pulmonary diagnostic approach for wheezing patients with normal spirometry?
- Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate Asthma.
- Severe Asthma: Lessons Learned from the NHLBI Severe Asthma Research Program.
- The C11orf30-LRRC32 region is associated with total serum IgE levels in Asthmatic patients.
- Asthma and pregnancy: do they give clues to abnormal antiviral activity?
- Efficacy in Asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial.
- How cytokines co-occur across Asthma patients: From bipartite network analysis to a molecular-based classification.
- Asthma diagnosis and treatment: Filling in the information gaps.
- Fluticasone furoate demonstrates efficacy in patients with Asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-control...
- What effect does Asthma treatment have on airway remodeling? Current perspectives.
- Obesity and Asthma: An association modified by age of Asthma onset.
- House dust mite sublingual immunotherapy: results of a US trial.
- Randomized trial of omalizumab (anti-IgE) for Asthma in inner-city children.
- Importance of hedgehog interacting protein and other lung function genes in Asthma.
- Mast cell phenotype, location, and activation in severe Asthma. Data from the Severe Asthma Research Program.
- Use of the Asthma Control Questionnaire to predict future risk of Asthma exacerbation.
- Vaccination of patients with mild and severe Asthma with a 2009 pandemic H1N1 influenza virus vaccine.
- Uniform definition of Asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma.
- The US Food and Drug Administration and long-acting beta2-agonists: the importance of striking the right balance between risks and benefits of therapy?
- The relationship of airway hyperresponsiveness and airway inflammation: Airway hyperresponsiveness in Asthma: its measurement and clinical significance.
- Predicting intermediate phenotypes in Asthma using bronchoalveolar lavage-derived cytokines.
- Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild Asthma.
- A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and Asthma.
- The National Institutes of Allergy and Infectious Diseases networks on Asthma in inner-city children: an approach to improved care.
- Asthma: clinical expression and molecular mechanisms.
- Comparative effect of body mass index on response to Asthma controller therapy.
- Three-dimensional imaging of ventilation dynamics in Asthmatics using multiecho projection acquisition with constrained reconstruction.
- Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent Asthma.
- The placebo effect in Asthma: Far more complex than simply "I shall please".
- Similar colds in subjects with Allergic asthma and nonatopic subjects after inoculation with rhinovirus-16.
- Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence.
- Short-term safety of somatropin inhalation powder in adults with mild to moderate Asthma.
- Attenuated P2X7 pore function as a risk factor for virus-induced loss of Asthma control.
- Learning from molecular sleuths.
- Daclizumab improves Asthma control in patients with moderate to severe persistent Asthma: a randomized, controlled trial.
- Host immune responses to rhinovirus: mechanisms in Asthma.
- Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe Asthma.
- Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in ...
- Evaluation of structure-function relationships in Asthma using multidetector CT and hyperpolarized He-3 MRI.
- Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge.
- The presence of rhinovirus in lower airways of patients with bronchial Asthma.
- Age-related changes in eosinophil function in human subjects.
- Molecular phenotyping of severe Asthma using pattern recognition of bronchoalveolar lavage-derived cytokines.
- Expert Panel Report 3: Moving forward to improve Asthma care.
- Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha.
- Modernization of the medical Sherlock Holmes.
- Severe Asthma in adults: what are the important questions?
- IL4R alpha mutations are associated with Asthma exacerbations and mast cell/IgE expression.
- Addressing issues of Asthma in inner-city children.
- Ligation of intercellular adhesion molecule 3 induces apoptosis of human blood eosinophils and neutrophils.
- The relationship of rhinovirus-associated Asthma hospitalizations with inhaled corticosteroids and smoking.
- Eosinophil beta 1 integrin activation state correlates with Asthma activity in a blind study of inhaled corticosteroid withdrawal.
- 6. Asthma: Factors underlying inception, exacerbation, and disease progression.
- Efficacy of montelukast during the allergy season in patients with chronic Asthma and seasonal aeroallergen sensitivity.
- Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent Asthma.
- Investigative bronchoprovocation and bronchoscopy in airway Diseases.
- Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions.
- Neural circuitry underlying the interaction between emotion and Asthma symptom exacerbation.
- Is interleukin-10 a "10" in virus-provoked Asthma?
- Correlation of systemic superoxide dismutase deficiency to airflow obstruction in Asthma.
Schools
University Of Wisconsin Medical School
Cincinnati Genl Hospital
University Of Wisconsin Madison
Procedures Preformed
- Allergy Shots
- Allergy Shots for Insect Stings
- Allergy Skin Testing
Conditions Treated
- Acute Sinusitis
- Allergic Rhinitis
- Angioedema
- Animal Allergies
- View All
Doctors Specialties
- Internal Medicine
- Allergy
- Immunology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAAAI)
Education
-
University of Wisconsin -
University Hospital - University of Cincinnati College of Medicine -
University of Wisconsin School of Medicine and Public Health
Hospital
-
University of Wisconsin Hospital and Clinics
Helpful Reviews
Similar Doctors
|
|
Dr. James E. Gern, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Wendy Mortimore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine M. Seroogy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer C. Passini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sameer K. Mathur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth H. Dilg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tosha B. Wetterneck, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeremy Bufford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jared I. Darveaux, MD
This Doctor is OpenDoctor Recommended.
|